Re: Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial
ESMO Open, vol.10, no.9, 2025 (SCI-Expanded, Scopus)
- Publication Type: Article / Letter
- Volume: 10 Issue: 9
- Publication Date: 2025
- Doi Number: 10.1016/j.esmoop.2025.105765
- Journal Name: ESMO Open
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
- Ankara University Affiliated: Yes